Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector

References

• Johnston MI, Fauci AS. An HIV vaccine--challenges and prospects. N Engl J Med 2008; 359:888 - 90; http://dx.doi.org/10.1056/NEJMp0806162; PMID: 18753644
   PubMed Web of Science ®Google Scholar
• Sekaly RP. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development?. J Exp Med 2008; 205:7 - 12; http://dx.doi.org/10.1084/jem.20072681; PMID: 18195078
   PubMed Web of Science ®Google Scholar
• Langhorne J, Ndungu FM, Sponaas AM, Marsh K. Immunity to malaria: more questions than answers. Nat Immunol 2008; 9:725 - 32; http://dx.doi.org/10.1038/ni.f.205; PMID: 18563083
   PubMed Web of Science ®Google Scholar
• Reyes-Sandoval A, Harty JT, Todryk SM. Viral vector vaccines make memory T cells against malaria. Immunology 2007; 121:158 - 65; http://dx.doi.org/10.1111/j.1365-2567.2006.02552.x; PMID: 17462077
   PubMed Web of Science ®Google Scholar
• Havenga M, Vogels R, Zuijdgeest D, Radosevic K, Mueller S, Sieuwerts M, et al. Novel replication-incompetent adenoviral B-group vectors: high vector stability and yield in PER.C6 cells. J Gen Virol 2006; 87:2135 - 43; http://dx.doi.org/10.1099/vir.0.81956-0; PMID: 16847108
   PubMed Web of Science ®Google Scholar
• Ly LH, McMurray DN. Tuberculosis: vaccines in the pipeline. Expert Rev Vaccines 2008; 7:635 - 50; http://dx.doi.org/10.1586/14760584.7.5.635; PMID: 18564018
   PubMed Web of Science ®Google Scholar
• Liniger M, Zuniga A, Naim HY. Use of viral vectors for the development of vaccines. Expert Rev Vaccines 2007; 6:255 - 66; http://dx.doi.org/10.1586/14760584.6.2.255; PMID: 17408374
   PubMed Web of Science ®Google Scholar
• Liniger M, Zuniga A, Tamin A, Azzouz-Morin TN, Knuchel M, Marty RR, et al. Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses. Vaccine 2008; 26:2164 - 74; PMID: 18346823
   PubMed Web of Science ®Google Scholar
• del Valle JR, Devaux P, Hodge G, Wegner NJ, McChesney MB, Cattaneo R. A vectored measles virus induces hepatitis B surface antigen antibodies while protecting macaques against measles virus challenge. J Virol 2007; 81:10597 - 605; http://dx.doi.org/10.1128/JVI.00923-07; PMID: 17634218
   PubMed Web of Science ®Google Scholar
• Schnell MJ. Viral vectors as potential HIV-1 vaccines. FEMS Microbiol Lett 2001; 200:123 - 9; http://dx.doi.org/10.1111/j.1574-6968.2001.tb10703.x; PMID: 11425463
   PubMed Web of Science ®Google Scholar
• Tangy F, Naim HY. Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector. Viral Immunol 2005; 18:317 - 26; http://dx.doi.org/10.1089/vim.2005.18.317; PMID: 16035943
   PubMed Web of Science ®Google Scholar
• Lorin C, Mollet L, Delebecque F, Combredet C, Hurtrel B, Charneau P, et al. A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV. J Virol 2004; 78:146 - 57; http://dx.doi.org/10.1128/JVI.78.1.146-157.2004; PMID: 14671096
   PubMed Web of Science ®Google Scholar
• Billeter MA, Naim HY, Udem SA. Reverse genetics of measles virus and resulting multivalent recombinant vaccines: applications of recombinant measles viruses. Curr Top Microbiol Immunol 2009; 329:129 - 62; http://dx.doi.org/10.1007/978-3-540-70523-9_7; PMID: 19198565
   PubMed Web of Science ®Google Scholar
• Radecke F, Spielhofer P, Schneider H, Kaelin K, Huber M, Dötsch C, et al. Rescue of measles viruses from cloned DNA. EMBO J 1995; 14:5773 - 84; PMID: 8846771
   PubMed Web of Science ®Google Scholar
• Desprès P, Combredet C, Frenkiel MP, Lorin C, Brahic M, Tangy F. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis. J Infect Dis 2005; 191:207 - 14; http://dx.doi.org/10.1086/426824; PMID: 15609230
   PubMed Web of Science ®Google Scholar
• Liniger M, Zuniga A, Morin TN, Combardiere B, Marty R, Wiegand M, et al. Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. Vaccine 2009; 27:3299 - 305; http://dx.doi.org/10.1016/j.vaccine.2009.01.057; PMID: 19200842
   PubMed Web of Science ®Google Scholar
• Singh M, Billeter MA. A recombinant measles virus expressing biologically active human interleukin-12. J Gen Virol 1999; 80:101 - 6; PMID: 9934691
   PubMed Web of Science ®Google Scholar
• Singh M, Cattaneo R, Billeter MA. A recombinant measles virus expressing hepatitis B virus surface antigen induces humoral immune responses in genetically modified mice. J Virol 1999; 73:4823 - 8; PMID: 10233943
   PubMed Web of Science ®Google Scholar
• Guerbois M, Moris A, Combredet C, Najburg V, Ruffié C, Février M, et al. Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic. Virology 2009; 388:191 - 203; http://dx.doi.org/10.1016/j.virol.2009.02.047; PMID: 19345390
   PubMed Web of Science ®Google Scholar
• Wang Z, Hangartner L, Cornu TI, Martin LR, Zuniga A, Billeter MA, et al. Recombinant measles viruses expressing heterologous antigens of mumps and simian immunodeficiency viruses. Vaccine 2001; 19:2329 - 36; http://dx.doi.org/10.1016/S0264-410X(00)00523-5; PMID: 11257357
   PubMed Web of Science ®Google Scholar
• Zuniga A, Wang Z, Liniger M, Hangartner L, Caballero M, Pavlovic J, et al. Attenuated measles virus as a vaccine vector. Vaccine 2007; 25:2974 - 83; http://dx.doi.org/10.1016/j.vaccine.2007.01.064; PMID: 17303293
   PubMed Web of Science ®Google Scholar
• Dilraj A, Cutts FT, de Castro JF, Wheeler JG, Brown D, Roth C, et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: a randomised trial. Lancet 2000; 355:798 - 803; http://dx.doi.org/10.1016/S0140-6736(99)95140-1; PMID: 10711928
   PubMed Web of Science ®Google Scholar
• Dilraj A, Sukhoo R, Cutts FT, Bennett JV. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination. Vaccine 2007; 25:4170 - 4; http://dx.doi.org/10.1016/j.vaccine.2007.03.003; PMID: 17408818
   PubMed Web of Science ®Google Scholar
• Bennett JV, Fernandez de Castro J, Valdespino-Gomez JL, Garcia-Garcia MdeL, Islas-Romero R, Echaniz-Aviles G, et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: randomized trials in Mexican schoolchildren. Bull World Health Organ 2002; 80:806 - 12; PMID: 12471401
   PubMed Web of Science ®Google Scholar
• Cutts FT, Clements CJ, Bennett JV. Alternative routes of measles immunization: a review. Biologicals 1997; 25:323 - 38; http://dx.doi.org/10.1006/biol.1997.0103; PMID: 9325001
   PubMed Web of Science ®Google Scholar
• Albrecht P, Herrmann K, Burns GR. Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods 1981; 3:251 - 60; http://dx.doi.org/10.1016/0166-0934(81)90062-8; PMID: 7334066
   PubMed Web of Science ®Google Scholar
• Spielhofer P, Bächi T, Fehr T, Christiansen G, Cattaneo R, Kaelin K, et al. Chimeric measles viruses with a foreign envelope. J Virol 1998; 72:2150 - 9; PMID: 9499071
   PubMed Web of Science ®Google Scholar
• Verhaagh S, de Jong E, Goudsmit J, Lecollinet S, Gillissen G, de Vries M, et al. Human CD46-transgenic mice in studies involving replication-incompetent adenoviral type 35 vectors. J Gen Virol 2006; 87:255 - 65; http://dx.doi.org/10.1099/vir.0.81293-0; PMID: 16432010
   PubMed Web of Science ®Google Scholar
• Yannoutsos N, Ijzermans JN, Harkes C, Bonthuis F, Zhou CY, White D, et al. A membrane cofactor protein transgenic mouse model for the study of discordant xenograft rejection. Genes Cells 1996; 1:409 - 19; http://dx.doi.org/10.1046/j.1365-2443.1996.d01-244.x; PMID: 9135084
   PubMed Web of Science ®Google Scholar
• Baricević M, Forcić D, Gulija TK, Jug R, Mazuran R. Determination of the coding and non-coding nucleotide sequences of genuine Edmonston-Zagreb master seed and current working seed lot. Vaccine 2005; 23:1072 - 8; http://dx.doi.org/10.1016/j.vaccine.2004.08.021; PMID: 15620481
   PubMed Web of Science ®Google Scholar
• Parks CL, Lerch RA, Walpita P, Wang HP, Sidhu MS, Udem SA. Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage. J Virol 2001; 75:921 - 33; http://dx.doi.org/10.1128/JVI.75.2.921-933.2001; PMID: 11134305
   PubMed Web of Science ®Google Scholar
• Johansson EL, Wassén L, Holmgren J, Jertborn M, Rudin A. Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 2001; 69:7481 - 6; http://dx.doi.org/10.1128/IAI.69.12.7481-7486.2001; PMID: 11705923
   PubMed Web of Science ®Google Scholar
• Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect Immun 1997; 65:1387 - 94; PMID: 9119478
   PubMed Web of Science ®Google Scholar
• Nardelli-Haefliger D, Wirthner D, Schiller JT, Lowy DR, Hildesheim A, Ponci F, et al. Specific antibody levels at the cervix during the menstrual cycle of women vaccinated with human papillomavirus 16 virus-like particles. J Natl Cancer Inst 2003; 95:1128 - 37; http://dx.doi.org/10.1093/jnci/djg018; PMID: 12902442
   PubMed Web of Science ®Google Scholar
• Mrkic B, Pavlovic J, Rülicke T, Volpe P, Buchholz CJ, Hourcade D, et al. Measles virus spread and pathogenesis in genetically modified mice. J Virol 1998; 72:7420 - 7; PMID: 9696838
   PubMed Web of Science ®Google Scholar